Bolondi, Luigi

Publishing since 1982 (Dinosaur)

Has published 158 publications in 29 years

Number of publications published per year by Bolondi, Luigi. (Source : PubMed)

Distribution of publications types for Bolondi, Luigi. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Peck-Radosavljevic M, Greten TF, Lammer J, Rosmorduc O, Sangro B, Santoro A, Bolondi L. Consensus on the current use of sorafenib for the treatment of hepatocellular carcinoma.  Eur J Gastroenterol Hepatol  2010;22;4  
•  Leoni S, Piscaglia F, Golfieri R, Camaggi V, Vidili G, Pini P, Bolondi L. The impact of vascular and nonvascular findings on the noninvasive diagnosis of small hepatocellular carcinoma based on the EASL and AASLD criteria.  Am. J. Gastroenterol.  2010;105;3  
•  Salvatore V, Vidili G, Sagrini E, Borghi A, Bolondi L. Contrast-Enhanced Ultrasonography Features of Extramedullary Hematopoiesis Presenting as a Presacral Mass: an Update of the Literature.  Ultraschall Med  2009  
•  Piscaglia F, Venturi A, Mancini M, Giangregorio F, Vidili G, Magnolfi F, Mirarchi M, Fornari F, Bolondi L. Diagnostic Features of Real-Time Contrast-Enhanced Ultrasound in Focal Nodular Hyperplasia of the Liver.  Ultraschall Med  2009  
•  Lanzi A, Gianstefani A, Mirarchi MG, Pini P, Conti F, Bolondi L. Liver AL amyloidosis as a possible cause of high liver stiffness values.  Eur J Gastroenterol Hepatol  2009  
•  Gramantieri L, Fornari F, Ferracin M, Veronese A, Sabbioni S, Calin GA, Grazi GL, Croce CM, Bolondi L, Negrini M. MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality.  Clin. Cancer Res.  2009;15;16  
•  Fornari F, Gramantieri L, Giovannini C, Veronese A, Ferracin M, Sabbioni S, Calin GA, Grazi GL, Croce CM, Tavolari S, Chieco P, Negrini M, Bolondi L. MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells.  Cancer Res.  2009;69;14  
•  Giovannini C, Gramantieri L, Chieco P, Minguzzi M, Lago F, Pianetti S, Ramazzotti E, Marcu KB, Bolondi L. Selective ablation of Notch3 in HCC enhances doxorubicin's death promoting effect by a p53 dependent mechanism.  J. Hepatol.  2009;50;5  
•  Corradi F, Piscaglia F, Flori S, D'Errico-Grigioni A, Vasuri F, Tamé MR, Andreone P, Boni P, Gianstefani A, Bolondi L. Assessment of liver fibrosis in transplant recipients with recurrent HCV infection: usefulness of transient elastography.  Dig Liver Dis  2009;41;3  
•  Cucchetti A, Piscaglia F, Caturelli E, Benvegnù L, Vivarelli M, Ercolani G, Cescon M, Ravaioli M, Grazi GL, Bolondi L, Pinna AD. Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population.  Annals of surgical oncology  2009;16;2  

[ See timeline ] [ See all publications ]